Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Hypertension. 2012 Jul 16;60(3):757–764. doi: 10.1161/HYPERTENSIONAHA.112.196501

Figure 2. Levels of PYY3-36 in the medium after incubation of SHR PGVSMCs (A) and GMCs (B) with PYY1-36.

Figure 2

Incubation was for 15 minutes at the indicated concentrations of PYY1-36 with or without sitagliptin. C: DPPIV activity as assessed by sigagliptin-inhibitable metabolism of PYY1-36 to PYY3-36 in SHR PGVSMCs and GMCs. Letters above bars indicate significantly different (Fisher’s LSD test) from basal (a) or from corresponding control (b).